United Therapeutics Corporation Cost of Services (Deprecated 2018-01-31)
United Therapeutics Corporation (UTHR) reported Cost of Services (Deprecated 2018-01-31) of $1.72 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-04-28.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2011-04-28
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for the quarter ending 2011-03-31 was $1.72M, a 49.30% increase year-over-year.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for the quarter ending 2010-12-31 was $1.64M, a 29.61% increase year-over-year.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for the quarter ending 2010-09-30 was $1.55M, a 31.72% increase year-over-year.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for the quarter ending 2010-06-30 was $1.41M, a 31.81% increase year-over-year.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for fiscal 2010 was $5.75M, a 29.74% increase from fiscal 2009.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for fiscal 2009 was $4.43M, a 42.52% increase from fiscal 2008.
- United Therapeutics Corporation cost of services (deprecated 2018-01-31) for fiscal 2008 was $3.11M.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2011-03-31 | $1.72M 10-Q · filed 2011-04-28 | $3.35M derived: sum of 2 quarters · filed 2011-04-28 | $4.91M derived: sum of 3 quarters · filed 2011-04-28 | $6.32M derived: sum of 4 quarters · filed 2011-04-28 |
| 2010-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $3.19M derived: sum of 2 quarters · filed 2011-02-24 | $4.60M derived: sum of 3 quarters · filed 2011-02-24 | $5.75M 10-K · filed 2011-02-24 |
| 2010-09-30 | $1.55M 10-Q · filed 2010-10-28 | $2.96M derived: sum of 2 quarters · filed 2010-10-28 | $4.11M 10-Q · filed 2010-10-28 | $5.38M derived: sum of 4 quarters · filed 2011-04-28 |
| 2010-06-30 | $1.41M 10-Q · filed 2010-07-28 | $2.56M 10-Q · filed 2010-07-28 | $3.82M derived: sum of 3 quarters · filed 2011-04-28 | $5.00M derived: sum of 4 quarters · filed 2011-04-28 |
| 2010-03-31 | $1.15M 10-Q · filed 2011-04-28 | $2.41M derived: sum of 2 quarters · filed 2011-04-28 | $3.59M derived: sum of 3 quarters · filed 2011-04-28 | $4.66M derived: sum of 4 quarters · filed 2011-04-28 |
| 2009-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $2.44M derived: sum of 2 quarters · filed 2011-02-24 | $3.51M derived: sum of 3 quarters · filed 2011-02-24 | $4.43M 10-K · filed 2011-02-24 |
| 2009-09-30 | $1.18M 10-Q · filed 2010-10-28 | $2.25M derived: sum of 2 quarters · filed 2010-10-28 | $3.17M 10-Q · filed 2010-10-28 | |
| 2009-06-30 | $1.07M 10-Q · filed 2010-07-28 | $1.99M 10-Q · filed 2010-07-28 | ||
| 2008-12-31 | $3.11M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |